Zobrazeno 1 - 10
of 85
pro vyhledávání: '"N. A. Bystrova"'
Publikováno v:
Медицинская иммунология, Vol 23, Iss 4, Pp 737-742 (2021)
Determination of interrelationships between impairments of laboratory parameters of immune and metabolic status in patients with chronic cerebral ischemia of I-II stages was carried out. The study included 104 patients, of which 76 were female and 28
Externí odkaz:
https://doaj.org/article/0c32eea8081b4fe1bbcd8c3b94631f17
Publikováno v:
Медицинская иммунология, Vol 23, Iss 4, Pp 957-962 (2021)
The study aimed to develop a personalized pharmacological correction of immune, metabolic and neuropsychiatric disorders in chronic cerebral ischemia (CCI) stages I and II. The study included 104 patients, of which 76 were female and 28 were male, wi
Externí odkaz:
https://doaj.org/article/fff6df38d96e4e6fb50d431519ec5c22
Publikováno v:
Медицинская иммунология, Vol 20, Iss 3, Pp 401-410 (2018)
The aim of the study was to determine efficiency of Glutoxim, aimed for correction of immune disorders. The drug was administered to the patients with chronic cerebral ischemia (CCI, Stage I and II) complicated by arterial hypertension. Increased con
Externí odkaz:
https://doaj.org/article/5c43671e252d4288a5b4d1f3a21fa828
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 18, Iss 2, Pp 91-98 (2016)
For correspondence: Konoplya Alexander Ivanovich. Address: 3,K. Marx St.,Kursk, 305041,Russian Federation. Tel.: job. (4712) 58-81-76; mob. (910) 317-87-88. E-mail: konoplya51@mail.ru.Aim. To study the corrective effects of allogeneic and xenogeneic
Externí odkaz:
https://doaj.org/article/a90e1291a1554bbbbefdb3c87924da7d
Publikováno v:
Russian Chemical Bulletin. 72:1268-1273
Publikováno v:
Russian Chemical Bulletin. 71:2395-2403
Publikováno v:
Russian Chemical Bulletin. 71:587-590
Publikováno v:
VII INTERNATIONAL CONFERENCE “SAFETY PROBLEMS OF CIVIL ENGINEERING CRITICAL INFRASTRUCTURES” (SPCECI2021).
Publikováno v:
Medicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 957-962 (2021)
The study aimed to develop a personalized pharmacological correction of immune, metabolic and neuropsychiatric disorders in chronic cerebral ischemia (CCI) stages I and II. The study included 104 patients, of which 76 were female and 28 were male, wi
Publikováno v:
Medicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 737-742 (2021)
Determination of interrelationships between impairments of laboratory parameters of immune and metabolic status in patients with chronic cerebral ischemia of I-II stages was carried out. The study included 104 patients, of which 76 were female and 28